Skip to main content
. 2018 Jan 24;3(1):e000283. doi: 10.1136/esmoopen-2017-000283

Table 3.

Univariate Cox regression analysis for overall survival (OS) from the first dose of intrathecal interleukin-2 (IL-2) for on-treatment characteristics

Variable Level Total N Total deaths Median OS HR 95% CI P value
Total IL-2 doses received during Induction
 Per dose 43 35 7.8 0.89 0.77 to 1.01 0.08
Dose reduction
 No 24 18 11.8
 Yes 19 17 5.1 1.73 0.88 to 3.41 0.11
CSF positive at baseline (N = 30): CSF clearing
 No 20 19 4.5
 Yes 9 8 9.3 0.98 0.42 to 2.29 0.96
 Missing 1 1 * * * *
CSF negative at baseline (N = 13): cytology conversion to positive
 No 7 3
 Yes 6 4 16.2 2.31 0.51 to 10.44 0.28

*Not available.

CSF, cerebrospinal fluid.